Cancer Risk Assessment – A Key Component of Our Care
Recent studies have shown among postmenopausal women with normal body mass indices (BMI), those with higher body fat levels had an increased risk for invasive breast cancer. This data was presented at the American Association for Cancer Research Special Conference, “Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes” held in January 2018.
What this means is that the newest and most effective way of measuring body composition has helped physicians and researchers determine that even women with normal BMI may be at risk for cancer due to their total body fat percentage. It appears the actual amount of body fat is more relevant than total body weight when it comes to cancer risk.
For years the BMI was the only tool used to measure obesity. BMI calculates the ratio of height versus weight, but does not measure the ratio of fat to muscle, nor does it measure the location where the fat is stored. These are critical pieces of information that often helps physicians determine how to fight the symptoms of aging, hormone imbalance, osteoporosis and cancer risk. The SECA mBCA Body Composition Analysis performed at AgeWell gets precisely to the exact fat and muscle stores as well as the health of the cells in the body, one determinant of cancer risk.
We also look at the other factors that might put a patient at risk for hormone-related cancers such as breast, uterine and ovarian cancer. If there is any indication of predisposition or a patient is seeking to further their health knowledge, we dig deeper. Predisposing factors might include:
Family history of breast cancer
Family history of uterine cancer
Family history of ovarian cancer
Higher concentrations of fat stored in the abdomen and breasts
History of synthetic hormone use
Extensive use of cosmetics, perfumes, dyes, etc.
Dr. Amy Garza uses the SECA body composition analysis and comprehensive urine hormone metabolite testing at her Amarillo, Texas anti-aging and sexual health practice to help identify a patient’s exposure and develop a plan to lower cancer risk.
Exciting New Research on PRP’s Impact on Cancer Stem Cells
In another, very exciting development, cancer researchers in Australia have found that PRP, platelet rich plasma, has been used to effectively halt the growth of cancer stem cells (CSC) via targeted eradication, all the while sparing normal stem cells. PRP therapy transforms growth factor beta, which plays a pivotal role in a number of cancers and their ability to metastasize. Studies indicate that PRPtherapy appears to significantly slow down or even halt the proliferation of CSCs. Compounds are currently being formulated and tested to advance these conclusions. New treatments for pancreatic, ovarian and colorectal cancers—using PRP as their basis—are currently in development.
While we don’t yet know the implications of this for our patients, Dr. Garza is following the research closely and is excited about the expanding horizons of PRP research and treatment.
AgeWell enables patients to receive the most advanced testing methodologies and procedures, such as PRP therapy and body composition analysis. This helps us, and our patients, to be as proactive as we can be in approaching aging and sexual health…and overall good patient health!
Contact us to make an appointment at AgeWell and to learn if you are at an increased risk for hormone-related cancers. Learn how we can help you reduce your risk today.